Royal Bank of Canada reissued their outperform rating on shares of Legend Biotech (NASDAQ:LEGN – Free Report) in a research note issued to investors on Friday, Benzinga reports. They currently have a $86.00 price target on the stock. A number of other equities research analysts have also recently commented on the company. TD Cowen decreased […]

Royal Bank of Canada reissued their outperform rating on shares of Exelixis (NASDAQ:EXEL – Free Report) in a research note published on Thursday, Benzinga reports. They currently have a $27.00 price target on the biotechnology company’s stock. Other equities analysts have also recently issued reports about the stock. Oppenheimer restated an outperform rating and set […]

Magnite (NASDAQ:MGNI – Get Free Report)‘s stock had its “outperform” rating restated by research analysts at Royal Bank of Canada in a report released on Friday, Benzinga reports. They currently have a $19.00 price objective on the stock. Royal Bank of Canada’s target price would suggest a potential upside of 38.48% from the stock’s previous […]

Royal Bank of Canada restated their outperform rating on shares of Ionis Pharmaceuticals (NASDAQ:IONS – Free Report) in a research report released on Thursday morning, Benzinga reports. They currently have a $70.00 target price on the stock. IONS has been the topic of a number of other research reports. Jefferies Financial Group initiated coverage on […]

Legend Biotech (NASDAQ:LEGN – Get Free Report)‘s stock had its “outperform” rating reiterated by analysts at Royal Bank of Canada in a report released on Friday, Benzinga reports. They currently have a $86.00 target price on the stock. Royal Bank of Canada’s target price would indicate a potential upside of 74.55% from the stock’s current […]

Stock analysts at Royal Bank of Canada initiated coverage on shares of Nasdaq (NASDAQ:NDAQ – Get Free Report) in a research note issued to investors on Friday, MarketBeat Ratings reports. The brokerage set an “outperform” rating and a $88.00 price target on the financial services provider’s stock. Royal Bank of Canada’s price target points to […]